Brawn Biotech Limited announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2018. For the quarter, the company reported revenue from operations of INR 149.591 million against INR 115.952 million a year ago. Profit from ordinary activities before exceptional items was INR 5.496 million against INR 8.474 million a year ago. Profit from ordinary activities before tax was INR 5.496 million against INR 8.474 million a year ago. Profit for the period was INR 3.931 million or INR 1.35 per basic and diluted share against INR 5.678 million or INR 1.90 per basic and diluted share a year ago. For the six months, the company reported revenue from operations of INR 285.209 million against INR 225.385 million a year ago. Profit from ordinary activities before exceptional items was INR 10.809 million against INR 11.023 million a year ago. Profit from ordinary activities before tax was INR 10.809 million against INR 11.023 million a year ago. Profit for the period was INR 7.659 million or INR 2.72 per basic and diluted share against INR 7.355 million or INR 2.46 per basic and diluted share a year ago.